Literature DB >> 25435652

Conditions presenting with symptoms of peripheral arterial disease.

Aditya M Sharma1, Patrick T Norton2, Daisy Zhu3.   

Abstract

Peripheral artery disease (PAD) is estimated to affect more than 20% of people older than 65 years. The vast majority of patients with symptoms suggestive of PAD have atherosclerosis often associated with conventional vascular risk factors such as smoking, diabetes, dyslipidemia, and inflammation. A minority of people presenting with symptoms suggesting PAD have an alternative etiology. These groups of disorders are often underdiagnosed, and if diagnosed correctly the diagnosis may be delayed. Understanding these pathologies well is important, as they can be very debilitating and optimal treatment may vary significantly. Inappropriate treatment of these disorders can lead to worsening morbidity and mortality. This article discusses the underlying causes of nonatherosclerotic PAD, including the diagnosis and treatment of these disorders.

Entities:  

Keywords:  fibromuscular dysplasia; iliac artery endofibrosis; interventional radiology; mimics of peripheral vascular disease; nonatherosclerotic peripheral artery disease; popliteal artery entrapment syndrome

Year:  2014        PMID: 25435652      PMCID: PMC4232436          DOI: 10.1055/s-0034-1393963

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.513


  64 in total

1.  Stationary arterial waves in magnetic resonance angiography.

Authors:  Patrick T Norton; Klaus D Hagspiel
Journal:  J Vasc Interv Radiol       Date:  2005-03       Impact factor: 3.464

2.  Long-term outcomes after revascularization for advanced popliteal artery entrapment syndrome with segmental arterial occlusion.

Authors:  Seong-Yup Kim; Seung-Kee Min; Sanghyun Ahn; Sang-Il Min; Jongwon Ha; Sang Joon Kim
Journal:  J Vasc Surg       Date:  2011-09-23       Impact factor: 4.268

3.  Cystic adventitial disease of the popliteal artery.

Authors:  S P Haid; J Conn; J J Bergan
Journal:  Arch Surg       Date:  1970-12

Review 4.  Endofibrosis and kinking of the iliac arteries in athletes: a systematic review.

Authors:  G Peach; G Schep; R Palfreeman; J D Beard; M M Thompson; R J Hinchliffe
Journal:  Eur J Vasc Endovasc Surg       Date:  2011-12-19       Impact factor: 7.069

5.  Detection and treatment of claudication due to functional iliac obstruction in top endurance athletes: a prospective study.

Authors:  G Schep; M H M Bender; G van de Tempel; P F F Wijn; W R de Vries; B C Eikelboom
Journal:  Lancet       Date:  2002-02-09       Impact factor: 79.321

Review 6.  Buerger's disease in the 21st century: diagnosis, clinical features, and therapy.

Authors:  Joseph L Mills
Journal:  Semin Vasc Surg       Date:  2003-09       Impact factor: 1.000

Review 7.  Behcet's Syndrome.

Authors:  Sam R Dalvi; Resit Yildirim; Yusuf Yazici
Journal:  Drugs       Date:  2012-12-03       Impact factor: 9.546

8.  Symptomatic lower extremity vasculitis in giant cell arteritis: a case series.

Authors:  Tanaz A Kermani; Eric L Matteson; Gene G Hunder; Kenneth J Warrington
Journal:  J Rheumatol       Date:  2009-09-15       Impact factor: 4.666

Review 9.  Treatment of vascular Ehlers-Danlos syndrome: a systematic review.

Authors:  David Bergqvist; Martin Björck; Anders Wanhainen
Journal:  Ann Surg       Date:  2013-08       Impact factor: 12.969

10.  Identification and treatment of arterial thrombophilia.

Authors:  Mark Y Chan; Richard C Becker
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-02
View more
  2 in total

1.  Intimomedial mucoid arterial degeneration, a rare arterial disorder of forensic significance.

Authors:  Kim Wiskott; Pia Genet; Johannes A Lobrinus; Tony Fracasso; Christelle Lardi
Journal:  Forensic Sci Med Pathol       Date:  2019-08-24       Impact factor: 2.007

2.  Two otherwise healthy young brothers present with intermittent claudication, just a coincidence?

Authors:  Thomas Clifford; Jonathan Moore
Journal:  BMJ Case Rep       Date:  2017-07-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.